Diego A. Pedroza, Ph.D.
@dapedroza.bsky.social
Instructor, MOSAIC K99/R00 scholar, Baylor College of Medicine
Reposted by Diego A. Pedroza, Ph.D.
Interested in novel therapies for #TripleNegative #BreastCancer? Drs. D. Pedroza, J Rosen et al have promising new findings. #AntiCSF1R #Immunochemotherapy @natcomms.nature.com #BCMCancerCenter @bcmhouston.bsky.social www.nature.com/articles/s41...
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers - Nature Communications
Metastatic triple negative breast cancer (mTNBC) has limited treatments options. Here, this group presents a combination of low-dose cyclophosphamide, anti-CSF1R, and anti-PD-1 therapies to boost immu...
www.nature.com
February 5, 2026 at 3:59 PM
Interested in novel therapies for #TripleNegative #BreastCancer? Drs. D. Pedroza, J Rosen et al have promising new findings. #AntiCSF1R #Immunochemotherapy @natcomms.nature.com #BCMCancerCenter @bcmhouston.bsky.social www.nature.com/articles/s41...
Reposted by Diego A. Pedroza, Ph.D.
4. A new @natcomms.nature.com paper from ACS-funded postdoctoral fellow Dr. @dapedroza.bsky.social at @bcmhouston.bsky.social describing a new combined immuno-chemotherapy approach that effectively targets macrophage-rich metastatic triple negative breast cancer.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers - Nature Communications
Metastatic triple negative breast cancer (mTNBC) has limited treatments options. Here, this group presents a combination of low-dose cyclophosphamide, anti-CSF1R, and anti-PD-1 therapies to boost immu...
www.nature.com
January 16, 2026 at 11:06 PM
4. A new @natcomms.nature.com paper from ACS-funded postdoctoral fellow Dr. @dapedroza.bsky.social at @bcmhouston.bsky.social describing a new combined immuno-chemotherapy approach that effectively targets macrophage-rich metastatic triple negative breast cancer.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Diego A. Pedroza, Ph.D.
AAMC: “Make no mistake: This was a decision critical to the future of the nation, and the Supreme Court made the wrong choice. History will look upon these mass National Institutes of Health (NIH) research grant terminations with shame.”
www.aamc.org/news/press-r...
www.aamc.org/news/press-r...
AAMC Statement on Supreme Court Decision Allowing NIH Grant Terminations to Proceed
The AAMC issued a statement regarding the Supreme Court's decision permitting the termination of NIH grants.
www.aamc.org
August 22, 2025 at 2:07 PM
AAMC: “Make no mistake: This was a decision critical to the future of the nation, and the Supreme Court made the wrong choice. History will look upon these mass National Institutes of Health (NIH) research grant terminations with shame.”
www.aamc.org/news/press-r...
www.aamc.org/news/press-r...
Reposted by Diego A. Pedroza, Ph.D.
If you think a golden ballroom is more important than childhood cancer research… I have nothing left to say to you. Please unfollow me.
#pediatriccancer #cancermom
#pediatriccancer #cancermom
August 5, 2025 at 9:40 PM
If you think a golden ballroom is more important than childhood cancer research… I have nothing left to say to you. Please unfollow me.
#pediatriccancer #cancermom
#pediatriccancer #cancermom
Reposted by Diego A. Pedroza, Ph.D.
The findings at the recent trial and today's Columbia chaos is pushing me to the edge.
I just sent the following email...
I just sent the following email...
June 18, 2025 at 7:29 PM
The findings at the recent trial and today's Columbia chaos is pushing me to the edge.
I just sent the following email...
I just sent the following email...
Reposted by Diego A. Pedroza, Ph.D.
Dayaaaaam
@angierasmussen.bsky.social thought you might appreciate our review of Bhattacharya’s first 75 days as NIH “Director.” www.panaccindex.info/p/jay-bhatta...
Jay Bhattacharya is Not the NIH Director
Seventy-Five Days of Embarrassing Ineptitude
www.panaccindex.info
June 17, 2025 at 10:14 PM
Dayaaaaam
Reposted by Diego A. Pedroza, Ph.D.
Huge win! Will definitely be watching to make sure Bhattacharya’s #NIH doesn’t skirt this ruling by sitting on grants like they did the ruling that transgender terminations are illegal.
🚨 BREAKING: Nearly 4 months the NIH cut its first grants, a judge has ruled that the directives and process that led to cuts are arbitrary and capricious.
"The explanations are bereft of reasoning — virtually in their entirety... unsupported by [facts]."
Each of them are VOID and ILLEGAL, he says.
"The explanations are bereft of reasoning — virtually in their entirety... unsupported by [facts]."
Each of them are VOID and ILLEGAL, he says.
June 16, 2025 at 7:48 PM
Huge win! Will definitely be watching to make sure Bhattacharya’s #NIH doesn’t skirt this ruling by sitting on grants like they did the ruling that transgender terminations are illegal.
Reposted by Diego A. Pedroza, Ph.D.
You'll read more about Judge Young's speech on this. And I'll post it here. A powerful proclamation of the Trump Administration's discriminatory actions and the Court's imperative to call it out.
Wow. Incredible hearing.
Wow. Incredible hearing.
June 16, 2025 at 6:29 PM
You'll read more about Judge Young's speech on this. And I'll post it here. A powerful proclamation of the Trump Administration's discriminatory actions and the Court's imperative to call it out.
Wow. Incredible hearing.
Wow. Incredible hearing.
Reposted by Diego A. Pedroza, Ph.D.
THIS IS IT! THIS IS HUGE!!
PLAINTIFF'S WIN!!
Judge Young rules that the NIH grant terminations at issue in these cases are illegal and therefore vacated. BOOM!
PLAINTIFF'S WIN!!
Judge Young rules that the NIH grant terminations at issue in these cases are illegal and therefore vacated. BOOM!
"This Court rules that the challenged directives . . . are arbitrary and capricious."
"They are of no force and effect."
"They are illegal and so are each of the terminations before this Court"
"They are of no force and effect."
"They are illegal and so are each of the terminations before this Court"
June 16, 2025 at 6:21 PM
THIS IS IT! THIS IS HUGE!!
PLAINTIFF'S WIN!!
Judge Young rules that the NIH grant terminations at issue in these cases are illegal and therefore vacated. BOOM!
PLAINTIFF'S WIN!!
Judge Young rules that the NIH grant terminations at issue in these cases are illegal and therefore vacated. BOOM!
Reposted by Diego A. Pedroza, Ph.D.
Quick vibe check at the NIH, per a staffer there:
"We have lost so many people: we have no comms, no HR, no acquisitions, no one to do travel or purchasing. So many people have left that there are chains of email bounces..."
"We have lost so many people: we have no comms, no HR, no acquisitions, no one to do travel or purchasing. So many people have left that there are chains of email bounces..."
June 12, 2025 at 4:44 PM
Quick vibe check at the NIH, per a staffer there:
"We have lost so many people: we have no comms, no HR, no acquisitions, no one to do travel or purchasing. So many people have left that there are chains of email bounces..."
"We have lost so many people: we have no comms, no HR, no acquisitions, no one to do travel or purchasing. So many people have left that there are chains of email bounces..."
Reposted by Diego A. Pedroza, Ph.D.
The rescission of the rescission has been rescinded.
So I guess that’s good? 🤡
So I guess that’s good? 🤡
NOT-OD-25-124: Notice of Rescission of Civil Rights Term and Condition of Award
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Notice of Rescission of Civil Rights Term and Condition of Award NOT-OD-25-124. NIH
grants.nih.gov
June 12, 2025 at 7:54 PM
The rescission of the rescission has been rescinded.
So I guess that’s good? 🤡
So I guess that’s good? 🤡
pmc.ncbi.nlm.nih.gov/articles/PMC.... Happy to share our review on preclinal models of metastatic TNBC which is now available to everyone.
Leveraging preclinical models of metastatic breast cancer
Women that present to the clinic with established breast cancer metastases have limited treatment options. Yet, the majority of preclinical studies are actually not directed at developing treatment re...
pmc.ncbi.nlm.nih.gov
May 1, 2025 at 2:43 AM
pmc.ncbi.nlm.nih.gov/articles/PMC.... Happy to share our review on preclinal models of metastatic TNBC which is now available to everyone.
Reposted by Diego A. Pedroza, Ph.D.
Thrilled to kick off this exciting project with an incredible team! Grateful for the support from the UT-MDACC Accelerator Grant as we push forward innovative drug development for IBC and other aggressive breast cancers. #IBC #breastcancer #bcsm
#TRIUMPH-IBC @mdanderson.bsky.social
#TRIUMPH-IBC @mdanderson.bsky.social
Our @mdanderson.bsky.social inflammatory breast cancer team led by @debeblab.bsky.social joined protein gurus Dr. Jen Maynard, Dr @annalee-nguyen.bsky.social & others @utaustin.bsky.social & won a $4M accelerator grant for our TRIUMPH-IBC drug development program!! So excited! #bcsm #cansky
March 10, 2025 at 4:23 AM
Thrilled to kick off this exciting project with an incredible team! Grateful for the support from the UT-MDACC Accelerator Grant as we push forward innovative drug development for IBC and other aggressive breast cancers. #IBC #breastcancer #bcsm
#TRIUMPH-IBC @mdanderson.bsky.social
#TRIUMPH-IBC @mdanderson.bsky.social